Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sirtris Pharmaceuticals, Inc. (SIRT) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Sirtris Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1388775.
Total stock buying since 2007: $0.
Total stock sales since 2007: $2,457,665.
Total stock option exercises since 2007: $228,395.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 173,251 | $2,262,057 | 292,271 | $217,146 |
| 2007 | 0 | $0 | 11,503 | $195,608 | 26,785 | $11,249 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-05 | 0 | $0 | 0 | $0 | 292,271 | $217,146 |
| 2008-04 | 0 | $0 | 22,129 | $293,152 | 0 | $0 |
| 2008-03 | 0 | $0 | 15,500 | $178,852 | 0 | $0 |
| 2008-02 | 0 | $0 | 6,547 | $80,541 | 0 | $0 |
| 2008-01 | 0 | $0 | 129,075 | $1,709,512 | 0 | $0 |
| 2007-11 | 0 | $0 | 11,503 | $195,608 | 26,785 | $11,249 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-05-29 | Westphal Christoph H (President and CEO) | Option Ex | 181,796 | .76 | 138,164 |
| 2008-05-28 | Brannelly Paul (VP Finance, Treasurer) | Option Ex | 14,643 | .42 | 6,150 |
| 2008-05-27 | Elliott Peter (Senior VP, Head of Development) | Option Ex | 95,832 | .76 | 72,832 |
| 2008-04-11 | Sinclair David | Sale | 10,100 | 13.28 | 133,378 |
| 2008-04-10 | Sinclair David | Sale | 9,900 | 13.25 | 131,214 |
| 2008-03-05 | Westphal Christoph H (President and CEO) | Sale | 6,810 | 11.55 | 78,648 |
| 2008-03-04 | Westphal Christoph H (President and CEO) | Sale | 8,690 | 11.53 | 100,204 |
| 2008-02-06 | Brannelly Paul (VP Finance, Treasurer) | Sale | 6,547 | 12.30 | 80,541 |
| 2008-01-24 | Brannelly Paul (VP Finance, Treasurer) | Sale | 13,096 | 12.81 | 167,772 |
| 2008-01-22 | Jirousek Michael (Senior VP, Research) | Sale | 20,000 | 12.57 | 249,646 |
| 2008-01-10 | Sinclair David | Sale | 10,000 | 13.81 | 138,110 |
| 2008-01-08 | Westphal Christoph H (President and CEO) | Sale | 40,000 | 13.93 | 557,225 |
| 2007-11-30 | Schimmel Paul | Sale | 11,503 | 17.00 | 195,608 |
| 2007-11-30 | Schimmel Paul | Option Ex | 26,785 | .42 | 11,249 |
Insider trading activities including stock purchases, stock sales, and option exercises of SIRT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sirtris Pharmaceuticals, Inc. (symbol SIRT, CIK number 1388775) see the Securities and Exchange Commission (SEC) website.